Neumeier Poma Investment Counsel Decreased By $3.41 Million Its Fabrinet (FN) Stake; Staar Surgical Co (STAA) Sentiment Is 1.77

November 15, 2017 - By Maria Brooks

STAAR Surgical Company designs, develops, makes and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company has market cap of $625.70 million. It operates in the ophthalmic surgical market segment. It currently has negative earnings. The Company’s principal products are intraocular lenses used in cataract surgery and implantable collamer lenses used in refractive surgery.

Neumeier Poma Investment Counsel Llc decreased Fabrinet (FN) stake by 11.84% reported in 2017Q2 SEC filing. Neumeier Poma Investment Counsel Llc sold 81,115 shares as Fabrinet (FN)’s stock declined 27.98%. The Neumeier Poma Investment Counsel Llc holds 603,835 shares with $25.76 million value, down from 684,950 last quarter. Fabrinet now has $1.15 billion valuation. The stock decreased 2.75% or $0.86 during the last trading session, reaching $30.59. About 2 shares traded. Fabrinet (NYSE:FN) has risen 8.67% since November 15, 2016 and is uptrending. It has underperformed by 8.03% the S&P500.

Analysts await Fabrinet (NYSE:FN) to report earnings on February, 5. They expect $0.46 EPS, down 31.34% or $0.21 from last year’s $0.67 per share. FN’s profit will be $17.29 million for 16.63 P/E if the $0.46 EPS becomes a reality. After $0.55 actual EPS reported by Fabrinet for the previous quarter, Wall Street now forecasts -16.36% negative EPS growth.

Since June 1, 2017, it had 0 insider purchases, and 1 insider sale for $1.94 million activity. Mitchell David T. sold $1.94M worth of stock or 52,500 shares.

Investors sentiment decreased to 0.96 in Q2 2017. Its down 0.61, from 1.57 in 2017Q1. It worsened, as 45 investors sold FN shares while 65 reduced holdings. 31 funds opened positions while 75 raised stakes. 33.21 million shares or 0.75% more from 32.97 million shares in 2017Q1 were reported. State Board Of Administration Of Florida Retirement Systems accumulated 14,133 shares or 0% of the stock. Capital Associates New York owns 10,300 shares for 0.66% of their portfolio. Invesco invested 0% of its portfolio in Fabrinet (NYSE:FN). Millennium Mgmt Ltd Liability Corp accumulated 71,689 shares. Tiaa Cref Investment Management Limited stated it has 0% of its portfolio in Fabrinet (NYSE:FN). The Texas-based Dimensional Fund Lp has invested 0.04% in Fabrinet (NYSE:FN). The Michigan-based Comerica State Bank has invested 0.01% in Fabrinet (NYSE:FN). Alps Advsrs reported 12,341 shares stake. Sei Investments Communications, Pennsylvania-based fund reported 1,396 shares. The Minnesota-based Walleye Trading Lc has invested 0% in Fabrinet (NYSE:FN). Thrivent Financial For Lutherans holds 34,740 shares or 0.01% of its portfolio. Profund Limited Liability Corp reported 0.01% stake. Teachers Retirement Systems Of The State Of Kentucky reported 29,569 shares stake. Argent Cap Mgmt Limited Liability Corp holds 0.19% of its portfolio in Fabrinet (NYSE:FN) for 114,202 shares. Whale Rock Cap Management Limited Liability stated it has 888,013 shares or 2.65% of all its holdings.

Among 7 analysts covering Fabrinet (NYSE:FN), 5 have Buy rating, 0 Sell and 2 Hold. Therefore 71% are positive. Fabrinet has $60 highest and $23 lowest target. $46.31’s average target is 51.39% above currents $30.59 stock price. Fabrinet had 36 analyst reports since August 14, 2015 according to SRatingsIntel. The stock of Fabrinet (NYSE:FN) has “Buy” rating given on Friday, July 14 by Stifel Nicolaus. On Tuesday, August 22 the stock rating was maintained by Northland Capital with “Buy”. The stock has “Strong Buy” rating by Needham on Monday, June 26. The firm has “Buy” rating by Stifel Nicolaus given on Tuesday, May 3. Zacks downgraded the stock to “Hold” rating in Thursday, August 20 report. Stifel Nicolaus maintained Fabrinet (NYSE:FN) rating on Monday, September 25. Stifel Nicolaus has “Buy” rating and $48.0 target. Northland Capital maintained it with “Outperform” rating and $27.50 target in Tuesday, November 3 report. The company was maintained on Monday, January 4 by Piper Jaffray. The stock of Fabrinet (NYSE:FN) earned “Overweight” rating by Piper Jaffray on Thursday, May 11. Stifel Nicolaus maintained Fabrinet (NYSE:FN) on Friday, October 27 with “Buy” rating.

Broadwood Capital Inc holds 21.56% of its portfolio in STAAR Surgical Company for 10.86 million shares. Palo Alto Investors Llc owns 3.53 million shares or 1.78% of their US portfolio. Moreover, Grandeur Peak Global Advisors Llc has 0.68% invested in the company for 436,035 shares. The Colorado-based Shine Investment Advisory Services Inc has invested 0.62% in the stock. Campbell & Co Investment Adviser Llc, a Maryland-based fund reported 26,080 shares.

Analysts await STAAR Surgical Company (NASDAQ:STAA) to report earnings on March, 1. They expect $0.03 earnings per share, up 200.00% or $0.02 from last year’s $0.01 per share. STAA’s profit will be $1.23M for 126.67 P/E if the $0.03 EPS becomes a reality. After $0.02 actual earnings per share reported by STAAR Surgical Company for the previous quarter, Wall Street now forecasts 50.00% EPS growth.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Twitter Auto Publish Powered By : XYZScripts.com